Concepedia

Shawn B. Jones

SB

Statistics

Publications

4

Citations

517

H-Index

4

Active since

1994

Affiliations

Pfizer (United States)(Current)

Shawn B. Jones is an author at Pfizer (United States) specializing in drug discovery, pharmacology, and neuropharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryNeuropharmacologyDementiaNeurologyTreatmentNeurosciencePharmacotherapyAlzheimer's Disease

Publications per year

1994–2016

4

Publications

4

Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease

Dane Liston, Jann A. Nielsen, Anabella Villalobos et al. · European Journal of Pharmacology · 2003 · 191 citations

Alzheimer's Disease, Medicine, Dementia +12

Clozapine is a potent and selective muscarinic M4 receptor agonist

Stevin H. Zorn, Shawn B. Jones, Karen Ward et al. · European Journal of Pharmacology Molecular Pharmacology · 1994 · 190 citations

Molecular Pharmacology, Functional Selectivity, Medicine +4

Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase

Anabella Villalobos, James F. Blake, Christopher K. Bíggers et al. · Journal of Medicinal Chemistry · 1994 · 109 citations · Full text

Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis

Kannan Thirunavukkarasu, Craig Swearingen, Guilherme Rocha et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 27 citations

1–4 of 4